{"transactions":[{"id":1018903,"issuer":{"id":6551,"kind":"organization","name":"Owlet, Inc.","symbol":"OWLT"},"owners":[{"id":74283,"kind":"person","name":"Eclipse Continuity GP I, LLC","position":1,"cik":"0001675124","reported_name":"Eclipse Continuity GP I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74284,"kind":"person","name":"Eclipse Early Growth Fund I, L.P.","position":2,"cik":"0001877287","reported_name":"Eclipse Early Growth Fund I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74285,"kind":"person","name":"Eclipse Early Growth GP I, LLC","position":3,"cik":"0001876955","reported_name":"Eclipse Early Growth GP I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74286,"kind":"person","name":"Eclipse Continuity Fund I, L.P.","position":4,"cik":"0001675126","reported_name":"Eclipse Continuity Fund I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":5,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":6,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Series B Warrants (Right to Purchase Shares of Common Stock)","published_at":"2025-10-15T22:56:41.000Z","date":"2025-10-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1166935,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC (\"Eclipse EG GP I\") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1166935},"source":{"system":"sec-edgar","filing":"0001193125-25-240517","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816708/000119312525240517/ownership.xml","form_type":"4"}},{"id":1018902,"issuer":{"id":6551,"kind":"organization","name":"Owlet, Inc.","symbol":"OWLT"},"owners":[{"id":74283,"kind":"person","name":"Eclipse Continuity GP I, LLC","position":1,"cik":"0001675124","reported_name":"Eclipse Continuity GP I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74284,"kind":"person","name":"Eclipse Early Growth Fund I, L.P.","position":2,"cik":"0001877287","reported_name":"Eclipse Early Growth Fund I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74285,"kind":"person","name":"Eclipse Early Growth GP I, LLC","position":3,"cik":"0001876955","reported_name":"Eclipse Early Growth GP I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74286,"kind":"person","name":"Eclipse Continuity Fund I, L.P.","position":4,"cik":"0001675126","reported_name":"Eclipse Continuity Fund I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":5,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":6,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Series A Warrants (Right to Purchase Shares of Common Stock)","published_at":"2025-10-15T22:56:41.000Z","date":"2025-10-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5300291,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC (\"Eclipse EG GP I\") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5300291},"source":{"system":"sec-edgar","filing":"0001193125-25-240517","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816708/000119312525240517/ownership.xml","form_type":"4"}},{"id":1018901,"issuer":{"id":6551,"kind":"organization","name":"Owlet, Inc.","symbol":"OWLT"},"owners":[{"id":74283,"kind":"person","name":"Eclipse Continuity GP I, LLC","position":1,"cik":"0001675124","reported_name":"Eclipse Continuity GP I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74284,"kind":"person","name":"Eclipse Early Growth Fund I, L.P.","position":2,"cik":"0001877287","reported_name":"Eclipse Early Growth Fund I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74285,"kind":"person","name":"Eclipse Early Growth GP I, LLC","position":3,"cik":"0001876955","reported_name":"Eclipse Early Growth GP I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74286,"kind":"person","name":"Eclipse Continuity Fund I, L.P.","position":4,"cik":"0001675126","reported_name":"Eclipse Continuity Fund I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":5,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":6,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Common Stock","published_at":"2025-10-15T22:56:41.000Z","date":"2025-10-10","kind":"grant","planned":false,"acquired":true,"shares":3898906,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 10, 2025, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the \"Common Stock\"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC (\"Eclipse EG GP I\") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":5665669,"source":{"system":"sec-edgar","filing":"0001193125-25-240517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816708/000119312525240517/ownership.xml","form_type":"4"}},{"id":1426042,"issuer":{"id":6551,"kind":"organization","name":"Owlet, Inc.","symbol":"OWLT"},"owners":[{"id":74283,"kind":"person","name":"Eclipse Continuity GP I, LLC","position":1,"cik":"0001675124","reported_name":"Eclipse Continuity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74284,"kind":"person","name":"Eclipse Early Growth Fund I, L.P.","position":2,"cik":"0001877287","reported_name":"Eclipse Early Growth Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74285,"kind":"person","name":"Eclipse Early Growth GP I, LLC","position":3,"cik":"0001876955","reported_name":"Eclipse Early Growth GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74286,"kind":"person","name":"Eclipse Continuity Fund I, L.P.","position":4,"cik":"0001675126","reported_name":"Eclipse Continuity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":5,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":6,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-08-22T20:52:56.000Z","date":"2024-08-20","kind":"exercise","planned":false,"acquired":false,"shares":12120,"price":1000,"value":12120000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On August 20, 2024, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") converted 12,120 shares of Series A Convertible Preferred Stock of the Issuer at an exchange ratio of 145.7726, pursuant to the terms and conditions of the Investment Agreement (Excluded Investors), dated February 17, 2023, by and among the Issuer, Eclipse EGF I and the other parties thereto. The number of shares and exchange ratio have been adjusted to reflect the 1-for-14 reverse stock split the Issuer completed on July 7, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"On August 20, 2024, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") converted 12,120 shares of Series A Convertible Preferred Stock of the Issuer at an exchange ratio of 145.7726, pursuant to the terms and conditions of the Investment Agreement (Excluded Investors), dated February 17, 2023, by and among the Issuer, Eclipse EGF I and the other parties thereto. The number of shares and exchange ratio have been adjusted to reflect the 1-for-14 reverse stock split the Issuer completed on July 7, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On August 20, 2024, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") converted 12,120 shares of Series A Convertible Preferred Stock of the Issuer at an exchange ratio of 145.7726, pursuant to the terms and conditions of the Investment Agreement (Excluded Investors), dated February 17, 2023, by and among the Issuer, Eclipse EGF I and the other parties thereto. The number of shares and exchange ratio have been adjusted to reflect the 1-for-14 reverse stock split the Issuer completed on July 7, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A Convertible Preferred Stock does not have an expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares of Common Stock are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC (\"Eclipse EG GP I\") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":8080,"derivative":{"exercise_price":0,"exercise_date":"2023-02-17","underlying":"Common Stock","underlying_shares":1766763},"source":{"system":"sec-edgar","filing":"0000950170-24-099898","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816708/000095017024099898/ownership.xml","form_type":"4"}},{"id":1426041,"issuer":{"id":6551,"kind":"organization","name":"Owlet, Inc.","symbol":"OWLT"},"owners":[{"id":74283,"kind":"person","name":"Eclipse Continuity GP I, LLC","position":1,"cik":"0001675124","reported_name":"Eclipse Continuity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74284,"kind":"person","name":"Eclipse Early Growth Fund I, L.P.","position":2,"cik":"0001877287","reported_name":"Eclipse Early Growth Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74285,"kind":"person","name":"Eclipse Early Growth GP I, LLC","position":3,"cik":"0001876955","reported_name":"Eclipse Early Growth GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74286,"kind":"person","name":"Eclipse Continuity Fund I, L.P.","position":4,"cik":"0001675126","reported_name":"Eclipse Continuity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":5,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":6,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-22T20:52:56.000Z","date":"2024-08-20","kind":"exercise","planned":false,"acquired":true,"shares":1766763,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On August 20, 2024, Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\") converted 12,120 shares of Series A Convertible Preferred Stock of the Issuer at an exchange ratio of 145.7726, pursuant to the terms and conditions of the Investment Agreement (Excluded Investors), dated February 17, 2023, by and among the Issuer, Eclipse EGF I and the other parties thereto. The number of shares and exchange ratio have been adjusted to reflect the 1-for-14 reverse stock split the Issuer completed on July 7, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares of Common Stock are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC (\"Eclipse EG GP I\") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":1766763,"source":{"system":"sec-edgar","filing":"0000950170-24-099898","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816708/000095017024099898/ownership.xml","form_type":"4"}},{"id":1604962,"issuer":{"id":6551,"kind":"organization","name":"Owlet, Inc.","symbol":"OWLT"},"owners":[{"id":74283,"kind":"person","name":"Eclipse Continuity GP I, LLC","position":1,"cik":"0001675124","reported_name":"Eclipse Continuity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74284,"kind":"person","name":"Eclipse Early Growth Fund I, L.P.","position":2,"cik":"0001877287","reported_name":"Eclipse Early Growth Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74285,"kind":"person","name":"Eclipse Early Growth GP I, LLC","position":3,"cik":"0001876955","reported_name":"Eclipse Early Growth GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74286,"kind":"person","name":"Eclipse Continuity Fund I, L.P.","position":4,"cik":"0001675126","reported_name":"Eclipse Continuity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":5,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":6,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant (Right To Buy)","published_at":"2024-03-04T21:17:26.000Z","date":"2024-02-29","kind":"purchase","planned":false,"acquired":true,"shares":1166935,"ownership":{"direct":false,"nature":"See footnotes."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 29, 2024, by the Issuer and Eclipse EGF I (the \"Warrant\"), the exercise price and the number of shares of the Issuer's Common Stock issuable upon exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant."},{"field":"shares","element":"transactionShares","label":"F6","text":"As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 29, 2024, by the Issuer and Eclipse EGF I (the \"Warrant\"), the exercise price and the number of shares of the Issuer's Common Stock issuable upon exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 29, 2024, by the Issuer and Eclipse EGF I (the \"Warrant\"), the exercise price and the number of shares of the Issuer's Common Stock issuable upon exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 29, 2024, by the Issuer and Eclipse EGF I (the \"Warrant\"), the exercise price and the number of shares of the Issuer's Common Stock issuable upon exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares of Series B Convertible Preferred Stock are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC (\"Eclipse EG GP I\") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":1166935,"derivative":{"exercise_price":7.7125,"exercise_date":"2024-02-29","expiration_date":"2029-03-01","underlying":"Class A Common Stock","underlying_shares":1166935},"source":{"system":"sec-edgar","filing":"0000950170-24-024848","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816708/000095017024024848/ownership.xml","form_type":"4"}},{"id":1604961,"issuer":{"id":6551,"kind":"organization","name":"Owlet, Inc.","symbol":"OWLT"},"owners":[{"id":74283,"kind":"person","name":"Eclipse Continuity GP I, LLC","position":1,"cik":"0001675124","reported_name":"Eclipse Continuity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74284,"kind":"person","name":"Eclipse Early Growth Fund I, L.P.","position":2,"cik":"0001877287","reported_name":"Eclipse Early Growth Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74285,"kind":"person","name":"Eclipse Early Growth GP I, LLC","position":3,"cik":"0001876955","reported_name":"Eclipse Early Growth GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74286,"kind":"person","name":"Eclipse Continuity Fund I, L.P.","position":4,"cik":"0001675126","reported_name":"Eclipse Continuity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":5,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":6,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-03-04T21:17:26.000Z","date":"2024-02-29","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":1000,"value":6000000.0,"ownership":{"direct":false,"nature":"See footnotes."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B Convertible Preferred Stock is convertible into shares of Common Stock. The conversion rate shall initially be 129.6596 shares of Common Stock per each share of Series B Convertible Preferred Stock, subject to adjustment from time to time pursuant to the terms and conditions of the Investment Agreement, dated February 25, 2024, by and among the Issuer and Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\"), amongst others."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Series B Convertible Preferred Stock is convertible into shares of Common Stock. The conversion rate shall initially be 129.6596 shares of Common Stock per each share of Series B Convertible Preferred Stock, subject to adjustment from time to time pursuant to the terms and conditions of the Investment Agreement, dated February 25, 2024, by and among the Issuer and Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\"), amongst others."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series B Convertible Preferred Stock does not have an expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Series B Convertible Preferred Stock is convertible into shares of Common Stock. The conversion rate shall initially be 129.6596 shares of Common Stock per each share of Series B Convertible Preferred Stock, subject to adjustment from time to time pursuant to the terms and conditions of the Investment Agreement, dated February 25, 2024, by and among the Issuer and Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\"), amongst others."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares of Series B Convertible Preferred Stock are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC (\"Eclipse EG GP I\") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":6000,"derivative":{"exercise_date":"2024-02-29","underlying":"Class A Common Stock","underlying_shares":777957},"source":{"system":"sec-edgar","filing":"0000950170-24-024848","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816708/000095017024024848/ownership.xml","form_type":"4"}},{"id":2001943,"issuer":{"id":6551,"kind":"organization","name":"Owlet, Inc.","symbol":"OWLT"},"owners":[{"id":74283,"kind":"person","name":"Eclipse Continuity GP I, LLC","position":1,"cik":"0001675124","reported_name":"Eclipse Continuity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74284,"kind":"person","name":"Eclipse Early Growth Fund I, L.P.","position":2,"cik":"0001877287","reported_name":"Eclipse Early Growth Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74285,"kind":"person","name":"Eclipse Early Growth GP I, LLC","position":3,"cik":"0001876955","reported_name":"Eclipse Early Growth GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74286,"kind":"person","name":"Eclipse Continuity Fund I, L.P.","position":4,"cik":"0001675126","reported_name":"Eclipse Continuity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":5,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":6,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Class A Common Stock","published_at":"2023-02-23T01:42:31.000Z","date":"2023-02-17","kind":"purchase","acquired":true,"shares":74204080,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 17, 2023, by the Issuer and Eclipse EGF I (the \"Warrant\"), the exercise price and the number of shares of the Issuer's Class A Common Stock issuable on exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Class A Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 17, 2023, by the Issuer and Eclipse EGF I (the \"Warrant\"), the exercise price and the number of shares of the Issuer's Class A Common Stock issuable on exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Class A Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 17, 2023, by the Issuer and Eclipse EGF I (the \"Warrant\"), the exercise price and the number of shares of the Issuer's Class A Common Stock issuable on exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Class A Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares of Series A are held of record by Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\"). Eclipse Early Growth GP I, LLC (\"Eclipse EG GP I\") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Lior Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EGF GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":74204080,"derivative":{"exercise_price":0.333,"exercise_date":"2023-02-17","expiration_date":"2028-02-17","underlying":"Class A Common Stock","underlying_shares":74204080},"source":{"system":"sec-edgar","filing":"0000899243-23-005904","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816708/000089924323005904/doc4.xml","form_type":"4"}},{"id":2001942,"issuer":{"id":6551,"kind":"organization","name":"Owlet, Inc.","symbol":"OWLT"},"owners":[{"id":74283,"kind":"person","name":"Eclipse Continuity GP I, LLC","position":1,"cik":"0001675124","reported_name":"Eclipse Continuity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74284,"kind":"person","name":"Eclipse Early Growth Fund I, L.P.","position":2,"cik":"0001877287","reported_name":"Eclipse Early Growth Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74285,"kind":"person","name":"Eclipse Early Growth GP I, LLC","position":3,"cik":"0001876955","reported_name":"Eclipse Early Growth GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74286,"kind":"person","name":"Eclipse Continuity Fund I, L.P.","position":4,"cik":"0001675126","reported_name":"Eclipse Continuity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":5,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":6,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2023-02-23T01:42:31.000Z","date":"2023-02-17","kind":"purchase","acquired":true,"shares":20200,"price":1000,"value":20200000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Series A Convertible Preferred Stock (\"Series A\") is convertible into shares of common stock of the Issuer. The conversion rate shall initially be 2,040.8163 shares of Class A Common Stock per each share of Series A, subject to adjustment from time to time pursuant to the terms and conditions of the Investment Agreement, dated February 17, 2023, by and among the Issuer and Eclipse Early Growth Fund I, L.P., amongst others."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A does not have an expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Series A Convertible Preferred Stock (\"Series A\") is convertible into shares of common stock of the Issuer. The conversion rate shall initially be 2,040.8163 shares of Class A Common Stock per each share of Series A, subject to adjustment from time to time pursuant to the terms and conditions of the Investment Agreement, dated February 17, 2023, by and among the Issuer and Eclipse Early Growth Fund I, L.P., amongst others."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares of Series A are held of record by Eclipse Early Growth Fund I, L.P. (\"Eclipse EGF I\"). Eclipse Early Growth GP I, LLC (\"Eclipse EG GP I\") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Lior Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EGF GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":20200,"derivative":{"exercise_price":1000,"exercise_date":"2023-02-17","underlying":"Class A Common Stock","underlying_shares":41224489},"source":{"system":"sec-edgar","filing":"0000899243-23-005904","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816708/000089924323005904/doc4.xml","form_type":"4"}},{"id":2871185,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":124375,"kind":"organization","name":"Eclipse GP III, LLC","position":1,"cik":"0001763854","reported_name":"Eclipse GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124376,"kind":"organization","name":"Eclipse Fund III, L.P.","position":2,"cik":"0001763853","reported_name":"Eclipse Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":3,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":4,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2021-02-09T19:57:04.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"price":0,"reported_value":6442717.58,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The convertible promissory note automatically converted into shares of the Issuer's Common Stock at the closing of the IPO."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities are held directly by Eclipse Fund III, L.P. (\"Eclipse III\"). Eclipse GP III, LLC (\"Eclipse III GP\") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"exercise_price":13.6,"expiration_date":"2022-12-11","underlying":"Common Stock","underlying_shares":473729},"source":{"system":"sec-edgar","filing":"0001209191-21-009051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1641394/000120919121009051/doc4.xml","form_type":"4"}},{"id":2871184,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":124375,"kind":"organization","name":"Eclipse GP III, LLC","position":1,"cik":"0001763854","reported_name":"Eclipse GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124376,"kind":"organization","name":"Eclipse Fund III, L.P.","position":2,"cik":"0001763853","reported_name":"Eclipse Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":3,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":4,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-02-09T19:57:04.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":3710257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities are held directly by Eclipse Fund III, L.P. (\"Eclipse III\"). Eclipse GP III, LLC (\"Eclipse III GP\") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3710257},"source":{"system":"sec-edgar","filing":"0001209191-21-009051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1641394/000120919121009051/doc4.xml","form_type":"4"}},{"id":2871183,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":124375,"kind":"organization","name":"Eclipse GP III, LLC","position":1,"cik":"0001763854","reported_name":"Eclipse GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124376,"kind":"organization","name":"Eclipse Fund III, L.P.","position":2,"cik":"0001763853","reported_name":"Eclipse Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":3,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":4,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-02-09T19:57:04.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":185512,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Eclipse Ventures Fund I, L.P. (\"Eclipse I\"). Eclipse Ventures GP I, LLC (\"Eclipse I GP\") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":185512},"source":{"system":"sec-edgar","filing":"0001209191-21-009051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1641394/000120919121009051/doc4.xml","form_type":"4"}},{"id":2871182,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":124375,"kind":"organization","name":"Eclipse GP III, LLC","position":1,"cik":"0001763854","reported_name":"Eclipse GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124376,"kind":"organization","name":"Eclipse Fund III, L.P.","position":2,"cik":"0001763853","reported_name":"Eclipse Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":3,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":4,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-02-09T19:57:04.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":877445,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Eclipse Ventures Fund I, L.P. (\"Eclipse I\"). Eclipse Ventures GP I, LLC (\"Eclipse I GP\") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":877445},"source":{"system":"sec-edgar","filing":"0001209191-21-009051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1641394/000120919121009051/doc4.xml","form_type":"4"}},{"id":2871181,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":124375,"kind":"organization","name":"Eclipse GP III, LLC","position":1,"cik":"0001763854","reported_name":"Eclipse GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124376,"kind":"organization","name":"Eclipse Fund III, L.P.","position":2,"cik":"0001763853","reported_name":"Eclipse Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":3,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":4,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-02-09T19:57:04.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":976852,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Eclipse Ventures Fund I, L.P. (\"Eclipse I\"). Eclipse Ventures GP I, LLC (\"Eclipse I GP\") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":976852},"source":{"system":"sec-edgar","filing":"0001209191-21-009051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1641394/000120919121009051/doc4.xml","form_type":"4"}},{"id":2871180,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":124375,"kind":"organization","name":"Eclipse GP III, LLC","position":1,"cik":"0001763854","reported_name":"Eclipse GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124376,"kind":"organization","name":"Eclipse Fund III, L.P.","position":2,"cik":"0001763853","reported_name":"Eclipse Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":3,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":4,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T19:57:04.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":473729,"price":13.6,"value":6442714.4,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities are held directly by Eclipse Fund III, L.P. (\"Eclipse III\"). Eclipse GP III, LLC (\"Eclipse III GP\") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":4183986,"source":{"system":"sec-edgar","filing":"0001209191-21-009051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1641394/000120919121009051/doc4.xml","form_type":"4"}},{"id":2871179,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":124375,"kind":"organization","name":"Eclipse GP III, LLC","position":1,"cik":"0001763854","reported_name":"Eclipse GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124376,"kind":"organization","name":"Eclipse Fund III, L.P.","position":2,"cik":"0001763853","reported_name":"Eclipse Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":3,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":4,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T19:57:04.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":3710257,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities are held directly by Eclipse Fund III, L.P. (\"Eclipse III\"). Eclipse GP III, LLC (\"Eclipse III GP\") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":3710257,"source":{"system":"sec-edgar","filing":"0001209191-21-009051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1641394/000120919121009051/doc4.xml","form_type":"4"}},{"id":2871178,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":124375,"kind":"organization","name":"Eclipse GP III, LLC","position":1,"cik":"0001763854","reported_name":"Eclipse GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124376,"kind":"organization","name":"Eclipse Fund III, L.P.","position":2,"cik":"0001763853","reported_name":"Eclipse Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":3,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":4,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T19:57:04.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":185512,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Eclipse Ventures Fund I, L.P. (\"Eclipse I\"). Eclipse Ventures GP I, LLC (\"Eclipse I GP\") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":2039809,"source":{"system":"sec-edgar","filing":"0001209191-21-009051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641394/000120919121009051/doc4.xml","form_type":"4"}},{"id":2871177,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":124375,"kind":"organization","name":"Eclipse GP III, LLC","position":1,"cik":"0001763854","reported_name":"Eclipse GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124376,"kind":"organization","name":"Eclipse Fund III, L.P.","position":2,"cik":"0001763853","reported_name":"Eclipse Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":3,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":4,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T19:57:04.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":877445,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Eclipse Ventures Fund I, L.P. (\"Eclipse I\"). Eclipse Ventures GP I, LLC (\"Eclipse I GP\") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":1854297,"source":{"system":"sec-edgar","filing":"0001209191-21-009051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641394/000120919121009051/doc4.xml","form_type":"4"}},{"id":2871176,"issuer":{"id":115613,"kind":"organization","name":"Lucira Health, Inc.","symbol":"LHDX"},"owners":[{"id":124375,"kind":"organization","name":"Eclipse GP III, LLC","position":1,"cik":"0001763854","reported_name":"Eclipse GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124376,"kind":"organization","name":"Eclipse Fund III, L.P.","position":2,"cik":"0001763853","reported_name":"Eclipse Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74288,"kind":"person","name":"Eclipse Ventures Fund I, L.P.","position":3,"cik":"0001641394","reported_name":"Eclipse Ventures Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74287,"kind":"person","name":"Eclipse Ventures GP I, LLC","position":4,"cik":"0001843678","reported_name":"Eclipse Ventures GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T19:57:04.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":976852,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a\none-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred\nStock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Eclipse Ventures Fund I, L.P. (\"Eclipse I\"). Eclipse Ventures GP I, LLC (\"Eclipse I GP\") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any."}],"balance_after":976852,"source":{"system":"sec-edgar","filing":"0001209191-21-009051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641394/000120919121009051/doc4.xml","form_type":"4"}}]}